New York, USA – June 16, 2021 – Creative Bioarray, the leading customer-focused biotechnology company focuses on providing biological and chemical products and developing solutions to improve research outcomes and dramatically increase the speed of success with a wide range of high quality and reliable cell culture related product. Recently, Creative Bioarray announced the release of its stem cell differentiation services to accelerate drug development.
Stem cells can be divided into embryonic stem cells (ESCs), adult stem cells (ASCs) and induced pluripotent stem cells (iPSCs) according to their different sources. According to their plasticity/regenerative potential, stem cells can also be divided into pluripotent stem cells that can differentiate into all possible cell types, including placental cells, pluripotent stem cells that can differentiate into closely related cell families, and pluripotent stem cells that can differentiate into placenta cells, oligopotent stem cells that can differentiate into a few cells and unipotent stem cells that can only produce their own cell types.
It usually requires a specific medium and a combination of multiple factors to induce stem cells to differentiate into specific cell types. With the development of research and technology, standardized stem cell culture and differentiation technology will lay the foundation for biological research and future stem cell therapy. Creative Bioarray is committed to providing comprehensive stem cell differentiation services to generate multiple terminal cell lineages from different types of stem cells. Rich experience in stem cell technology can help customers accelerate research and drug development.
Creative Bioarray is capable to provide a complete service portfolio to differentiate different types of stem cells into multiple cell types:
Directional Differentiation of iPSC: Adult cells can be reprogrammed into induced pluripotent stem cells (iPSC). They can differentiate into all possible cell types of the three germ layer lineages in the body, such as liver cells, nerve cells, immune cells, and cardiomyocytes.
Directed Differentiation of Embryonic Stem Cells: Embryonic stem cells (ESC) are pluripotent stem cells derived from the undifferentiated inner cell mass of an embryo. Their morphology and structure are similar to early embryonic cells. Embryonic stem cells can differentiate into all possible cell types of the three main germ layers, such as osteoblasts and hematopoietic lineages.
Directed Differentiation of ASC: Adult stem cells (ASC) are undifferentiated cells in developing tissues, such as bone marrow, brain, liver, skeletal muscle, and skin. They can produce certain cell types from their original organs and may even regenerate entire organs. Mesenchymal stem cells (MSC), hematopoietic stem cells (HSC) and neural stem cells (NSC) are widely used adult stem cells.
“Creative Bioarray can provide more predictive in vitro physiological models for biological and clinical research. The differentiated stem cells will be fully identified and well cryopreserved. We also provide a flexible customized service platform for stem cell-based research at a competitive price.” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “If you need to start with stem cell differentiation, but there is no established plan, our experienced scientific team has the ability to provide customized services to help you generate the cell types you need.”
About Creative Bioarray
As a leading customer-focused biotechnology company based in New York, Creative Bioarray is capable to provide biological and chemical products, and strive for solutions that can improve research outcomes and dramatically speed up the research and development progress. With years of efforts, Creative Bioarray has become one of the world’s top suppliers with innovative high-quality products and services related to cell culture.